BVF Partners LP, acting on behalf of funds under its management, declared to the AMF that on December 29 it had fallen below the threshold of 5% of Erytech Parma's capital and held, on behalf of the said funds, 0.31% of the capital and 0.30% of the voting rights.

On December 28, the declaring party had crossed the 5% voting rights threshold and held, at that date, 5.20% of the capital and 4.97% of the voting rights of this biopharmaceutical company. These threshold crossings resulted from the sale of shares on the market.

Copyright (c) 2023 CercleFinance.com. All rights reserved.